Abstract
Background Behavioral inhibition (BI) is a temperament style characterized by heightened reactivity and negative affect in response to novel people and situations, and it is a strong predictor of anxiety problems later in life. However, not all BI children develop anxiety problems and mounting evidence suggests that how one manages their cognitive resources (cognitive control) influences anxiety risk. The present study tests whether more (proactive control) or less (reactive control) planful cognitive strategies moderate relations between BI and anxiety.
Methods Participants included 144 adolescents (55.9% female) whose temperament was assessed during toddlerhood. In adolescence (Mage = 15.4 years), participants completed an AX Continuous Performance Test while EEG was recorded in order to disentangle neural activity related to proactive (cue-locked P3b) and reactive (probe-locked N2) control.
Results BI was associated with greater total anxiety scores only among adolescents with smaller ΔP3bs and larger ΔN2s – a pattern consistent with decreased reliance on proactive strategies and increased reliance on reactive strategies. Additionally, a larger ΔP3b was associated with greater total anxiety scores.
Conclusions BI relates to risk for anxiety specifically among adolescents who rely less on proactive strategies and more on reactive control strategies. Results further suggest that proactive control differentiates a BI-related etiological pathway to anxiety from a more general pathway to anxiety occurring regardless of BI level. Thus, developmental context (i.e., temperament) moderates the association between anxiety and proactive control. The present study is the first to characterize how proactive and reactive control uniquely relate to pathways toward anxiety risk.
- anxiety
- cognitive control
- behavioral inhibition
- EEG
- adolescence
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the National Institute of Mental Health, Grand/Award Number: U01MH093349 (to N. A. F.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Maryland College Park IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study may be made available from the corresponding author, E. A. V., upon reasonable request.
